The introduction of nicotinamide as being a nicotine substitution in e-cigarette and smokeless merchandise represents a big regulatory obstacle for your FDA. Nicotinamide does not have nicotinic receptor agonist action and is thought to act as a sedative at large dosages6. The promises made by Nicotine River, ECBlend, and also other suppliers that